Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses
about
The role of CA125 in clinical practiceCurrent clinical application of serum biomarkers to detect ovarian cancerDiagnostic value of ultrasound indicators of neoplastic risk in preoperative differentiation of adnexal masses.Investigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the NetherlEstimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.Comparison of three malignancy risk indices and CA-125 in the preoperative evaluation of patients with pelvic masses.Management of gynaecological cancersCurrent state of biomarker development for clinical application in epithelial ovarian cancer.[Ovarian tumors in postmenopausal women: report of 100 cases and review of the literature]Comparison of four malignancy risk indices in the detection of malignant ovarian masses.Human epididymis protein 4 reference limits and natural variation in a Nordic reference populationIs Risk Malignancy Index a Useful Tool for Predicting Malignant Ovarian Masses in Developing Countries?Multianalyte assay systems in the differential diagnosis of ovarian cancer.Adnexal masses suspected to be benign treated with laparoscopyManagement of a suspicious adnexal mass: a clinical practice guideline.An Evaluation of the Applicability of the Risk of Malignancy Index for Adnexal Masses to Patients Seen at a Tertiary Hospital in Chandigarh, IndiaValidity of Cancer Antigen-125 (CA-125) and Risk of Malignancy Index (RMI) in the Diagnosis of Ovarian CancerClinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor MarkersDiagnostic Value of the Risk of Malignancy Index (RMI) for Detection of Pelvic Malignancies Compared with Pathology.Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trialEvaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal MassCombined Application of Ultrasound and CT Increased Diagnostic Value in Female Patients with Pelvic MassesRisk of malignancy index as an evaluation of preoperative pelvic mass.Risk of malignancy index is not sensitive in detecting non-epithelial ovarian cancer and borderline ovarian tumor.Pain evaluation during gynaecological surveillance in women with Lynch syndrome.Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspectiveA prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen.Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1-4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?Does size matter? Retrospective analysis of large gynecologic tumors.
P2860
Q24672539-E3302E9D-5777-4948-90FA-347BDDE94C51Q26768709-1001B8D6-CAA2-445D-8A2B-2011FCFA45D5Q30396133-3083B7BC-F193-4395-931F-454F8D09066FQ30407535-03AF98F7-FF57-4F53-B641-7B9608A2AA8BQ33845896-571FA3CE-CF45-4F9B-BF6D-AE76ADE1BAE0Q33937360-4F91E4BD-1EBA-43BF-B75E-50EC0906D2D9Q33939918-5BDC1D96-24E5-46D7-9413-642E9F4198DBQ35100951-0E80AA6E-799D-4F4D-B51F-91E93C5C26EDQ35226267-0CD21916-3068-4C86-8359-E0C90CBF0B4CQ35285326-CEC78056-911F-4BFF-A513-50645A9E54A0Q35605987-719329F3-C574-46DD-9B62-B3E87E25AC7DQ35817413-CB616F64-C46B-41FF-99EF-C8414B3AA2C8Q35854476-E32B115E-EA0E-4E4E-B89D-BD4D5D3CE663Q36124571-EE03BE50-936E-4FAC-9BC7-FB6FD2AB8C87Q36136882-35ED2936-FCA8-4BF7-87FB-240294602B1CQ36337239-4A32DC51-5482-48C1-B579-7447BAF9F6D6Q36370010-6F78869B-DA30-4B36-B9EC-B8326129D5DFQ36372283-14A1AA66-E146-47E2-9715-1116539AC2E9Q36429252-3D4DB4BA-8E95-4704-9591-9306F8C77B3EQ36620469-6178061B-0E2D-43E6-83AE-0FE7E965AEC2Q37012893-9C4A25B7-B902-4C99-86CB-8410CF49AFD6Q37201766-399F0294-2C61-4FDC-ABCF-0FA5F19C2615Q37404748-ACC5B5AD-A0A9-46A5-95FA-F48E7596C62CQ37493854-BC7DF6AC-D2C7-43E4-8ECF-C879425DABC3Q37611444-7474BA23-402F-468E-944B-9C823C17ECCBQ37710179-29AC2E8C-69F9-45FB-9B00-97DC028A2ED4Q38649539-785B8699-D0FB-4595-9759-026E1D96886CQ41395692-18FB2336-51A1-4252-866E-03CD4E5A4A01Q41512697-402BBD8C-24D6-4907-B8D2-40D31F8219D4Q47098698-79591327-D72F-474D-9A4B-625981A9960CQ47172994-972B674E-7F97-469A-BCFE-DB4D53C326AD
P2860
Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses
description
scientific article published on 01 August 1996
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 1996
@uk
name
Evaluation of a risk of malign ...... ive diagnosis of pelvic masses
@en
Evaluation of a risk of malign ...... ive diagnosis of pelvic masses
@nl
type
label
Evaluation of a risk of malign ...... ive diagnosis of pelvic masses
@en
Evaluation of a risk of malign ...... ive diagnosis of pelvic masses
@nl
prefLabel
Evaluation of a risk of malign ...... ive diagnosis of pelvic masses
@en
Evaluation of a risk of malign ...... ive diagnosis of pelvic masses
@nl
P2093
P1476
Evaluation of a risk of malign ...... ive diagnosis of pelvic masses
@en
P2093
F E Skjeldestad
S Tingulstad
T Halvorsen
P304
P356
10.1111/J.1471-0528.1996.TB09882.X
P407
P577
1996-08-01T00:00:00Z